Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
10 YR |
Sex |
Female |
Age of Onset(If not a control) |
5 MO |
Age at Diagnosis(If not a control) |
14 MO |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
Caucasian |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
ECHS1: C.518C>T (P.ALA173VAL)
ECHS1: C.523G>A (P.GLY175SER) |
Zygosity: |
Compound Heterozygous |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
5 MONTHS |
Age at Diagnosis: |
14 MONTHS |
In Utero History Information |
|
|
Birth History Information |
|
|
Dysmorphic Features |
|
|
Neurological Symptoms |
|
Dystonia Hypertonia Hypotonia Sleep abnormalities
|
Additional Information: |
ABNORMAL BRAIN MRI - BASAL GANGLIA INTENSITY; ABNORMAL CEREBRAL WHITE MATTER MORPHOLOGY, CEREBRAL ATROPHY, ABNORMAL MIDBRAIN MORPHOLOGY; OBSTRUCTIVE SLEEP APNEA |
Optical and Audiological Symptoms |
|
Nystagmus Defective hearing
|
Additional Information: |
ABNORMAL AND UNCONTROLLED EYE MOVEMENT, RETINOPATHY, PTOSIS, AND OPTIC ATROPHY |
Musculoskeletal Symptoms |
|
Non-ambulatory
|
Additional Information: |
SPASTICITY, BABINSKI; ABNORMAL UPPER AND LOWER LIMBS; HIP DISLOCATION; ACETABULAR DYSPLASIA; ABNORMAL JOINT MORPHOLOGY |
Developmental Milestones |
|
Delayed speech and language development Global developmental delay
|
Additional Information: |
NON-VERBAL |
Gastrointestinal Symptoms |
|
Eating difficulties
|
Additional Information: |
GASTROESOPHAGEAL REFLUX |
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Additional Information: |
HYPOVENTILATION |
Cognitive and Behavioral Symptoms |
|
|
Intellectual Disability: |
Severe |
Additional Information |
Uncategorized Symptoms: |
SUPERNUMERARY NIPPLE; BRUXISM |
Testing Performed |
Neurological Testing: |
MRI - SUGGESTIVE OF LEIGH OR METABOLIC ENCEPHALOPATHY - BASAL GANGLIA, WHITE MATTER ABNORMALITIES. |
Metabolic, Hematologic, and Endocrinologic Testing: |
HEMATEMESIS; ABNORMAL METABOLISM/HOMEOSTASIS |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy Wheelchair or ambulation devices Orthotics
|
Surgeries |
G-TUBE |
Additional Testing: |
CPAP, VISION THERAPY |
Medications |
|
DOJOLVI, LEUCOVORIN, NAC, B1, B2, BIOTIN, L-CARNITINE |
Family History |
Remarks |
See "Phenotypic Data" tab |